Thursday, January 3, 2008

Ranbaxy Sees Strong Growth In 2008

India''s most aggressive pharma company Ranbaxy is going to get more aggressive in 2008. The company expects strong earnings growth in the current year with margin up from last year''s 16 per cent. Ranbaxy will be increasingly focusing on the emerging markets in 2008. One thing that could help the company is that it is on track to demerge its R&D businesses and once demerged it will be listed probably some time in the second half of 2008. In order to list company''s novel drug discovery research (NDDR) operations in first half of 2008 the specific framework and details of de-merger will be announced soon.

No comments: